Q1 2024 Holdings
Filed 2024-05-15 | 72 holdings | $361.3M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Spdr SER TR(XBI)Put | S&P BIOTECH | 78464A870 | $23.7M | 250,000 | 6.6% |
| Axsome Therapeutics Inc(AXSM) | COM | 05464T104 | $16.8M | 210,000 | 4.6% |
| Sarepta Therapeutics Inc(SRPT) | COM | 803607100 | $16.2M | 125,000 | 4.5% |
| Biohaven LTD(BHVN) | COM | G1110E107 | $15.6M | 285,000 | 4.3% |
| Moonlake Immunotherapeutics(MLTX) | CLASS A ORD | 61559X104 | $15.1M | 300,000 | 4.2% |
| Roivant Sciences LTD(ROIV) | SHS | G76279101 | $13.7M | 1,300,000 | 3.8% |
| TG Therapeutics Inc(TGTX) | COM | 88322Q108 | $12.5M | 825,000 | 3.5% |
| Viridian Therapeutics Inc(VRDN) | COM | 92790C104 | $10.9M | 625,000 | 3.0% |
| Tarsus Pharmaceuticals Inc(TARS) | COM | 87650L103 | $10.9M | 300,000 | 3.0% |
| Crinetics Pharmaceuticals in(CRNX) | COM | 22663K107 | $9.4M | 200,000 | 2.6% |
| Alnylam Pharmaceuticals Inc(ALNY) | COM | 02043Q107 | $9.0M | 60,000 | 2.5% |
| Soleno Therapeutics Inc(SLNO) | COM | 834203309 | $8.6M | 200,000 | 2.4% |
| Savara Inc(SVRA) | COM | 805111101 | $8.0M | 1,600,000 | 2.2% |
| Apellis Pharmaceuticals Inc(APLS) | COM | 03753U106 | $7.6M | 130,000 | 2.1% |
| Perspective Therapeutics Inc | COM | 46489V104 | $7.1M | 6,000,000 | 2.0% |
| Blueprint Medicines Corp(2L9) | COM | 09627Y109 | $6.9M | 72,761 | 1.9% |
| Aerovate Therapeutics Inc | COM | 008064107 | $6.7M | 225,000 | 1.8% |
| Viking Therapeutics Inc(VKTX)Call | COM | 92686J106 | $6.6M | 80,000 | 1.8% |
| Vaxcyte Inc(PCVX) | COM | 92243G108 | $6.5M | 95,000 | 1.8% |
| Cabaletta BIO Inc(CABA) | COM | 12674W109 | $6.4M | 375,000 | 1.8% |
| Viking Therapeutics Inc(VKTX) | COM | 92686J106 | $6.0M | 73,002 | 1.7% |
| Rhythm Pharmaceuticals Inc(RYTM) | COM | 76243J105 | $5.4M | 125,000 | 1.5% |
| Bridgebio Pharma Inc(BBIO) | COM | 10806X102 | $5.4M | 175,000 | 1.5% |
| Replimune Group Inc(REPL) | COM | 76029N106 | $5.3M | 650,000 | 1.5% |
| Cytokinetics Inc(CYTK)Call | COM NEW | 23282W605 | $5.3M | 75,000 | 1.5% |
| Phathom Pharmaceuticals Inc(PHAT) | COM | 71722W107 | $5.2M | 485,000 | 1.4% |
| Immunovant Inc(IMVT)Call | COM | 45258J102 | $4.8M | 150,000 | 1.3% |
| Acadia Pharmaceuticals Inc(ACAD) | COM | 004225108 | $4.2M | 225,000 | 1.2% |
| Insmed Inc(INSM) | COM PAR $.01 | 457669307 | $4.1M | 150,000 | 1.1% |
| Tenaya Therapeutics Inc(TNYA) | COM | 87990A106 | $4.1M | 775,000 | 1.1% |
| Immunovant Inc(IMVT) | COM | 45258J102 | $4.0M | 125,000 | 1.1% |
| Spyre Therapeutics Inc(SYRE) | COM NEW | 00773J202 | $3.8M | 100,000 | 1.0% |
| Acadia Pharmaceuticals Inc(ACAD)Call | COM | 004225108 | $3.7M | 200,000 | 1.0% |
| Syndax Pharmaceuticals Inc(SNDX) | COM | 87164F105 | $3.6M | 150,000 | 1.0% |
| Intra-Cellular Therapies Inc(ITCIEUR)Call | COM | 46116X101 | $3.5M | 50,000 | 1.0% |
| Engene Holdings Inc(ENGN) | COM | 29286M105 | $3.4M | 200,000 | 0.9% |
| CG Oncology Inc(CGON) | COM | 156944100 | $3.3M | 75,000 | 0.9% |
| Structure Therapeutics Inc(GPCR) | SPONSORED ADS | 86366E106 | $3.2M | 75,000 | 0.9% |
| Helix Acquisition Corp II | CL A ORD SHS | G4444H101 | $3.1M | 300,000 | 0.9% |
| Cogent Biosciences Inc(COGT) | COM | 19240Q201 | $3.0M | 450,000 | 0.8% |
| Aquestive Therapeutics Inc(AQST) | COM | 03843E104 | $3.0M | 702,941 | 0.8% |
| Deciphera Pharmaceuticals in(DCPHEUR) | COM | 24344T101 | $2.8M | 176,513 | 0.8% |
| Taysha Gene Therapies Inc(TSHA) | COM SHS | 877619106 | $2.7M | 950,000 | 0.8% |
| Rapt Therapeutics Inc(RAPTEUR)Call | COM | 75382E109 | $2.7M | 300,000 | 0.7% |
| Geron Corp(GERN) | COM | 374163103 | $2.6M | 800,000 | 0.7% |
| Marinus Pharmaceuticals Inc(MRNS*) | COM NEW | 56854Q200 | $2.6M | 285,000 | 0.7% |
| Altimmune Inc(ALT) | COM NEW | 02155H200 | $2.5M | 250,000 | 0.7% |
| Regenxbio Inc(RGNX) | COM | 75901B107 | $2.5M | 120,000 | 0.7% |
| Krystal Biotech Inc(KRYS) | COM | 501147102 | $2.5M | 14,000 | 0.7% |
| Kalvista Pharmaceuticals Inc(KALV) | COM | 483497103 | $2.4M | 200,000 | 0.7% |